Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073420 · ClinicalTrials.gov registry record
Medtronic Cardiac Surgery PMCF Registry
A clinical trial of Valve Disease, Heart, sponsored by Medtronic Cardiac Surgery.
- Recruiting
- Registry status
- 2,700
- Enrollment target
- 20
- Study locations
NCT04073420: Recruiting study of Valve Disease, Heart, sponsored by Medtronic Cardiac Surgery.
NCT04073420 is a study of Valve Disease, Heart that is actively recruiting participants, run by Medtronic Cardiac Surgery. The registered enrollment target is 2,700 participants, above the 191-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (1314% higher). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04073420, a study of Valve Disease, Heart, is actively recruiting participants, sponsored by Medtronic Cardiac Surgery.
- RECRUITING
- Registry status
- 2,700 participants
- Enrollment target
- 20
- Study locations
Study Summary
This registry is being conducted to support ongoing post-market surveillance activities.
Conditions Studied
Interventions
- DEVICE Surgical Heart Valve Repair Products
- DEVICE Surgical Heart Valve Replacement Products
Study Locations (20)
Other
- Allgemeines Krankenhaus - Universitätskliniken Wien - Vienna
- UZ Leuven - Leuven
- Hôpital Haut-Lévêque - CHU de Bordeaux - Pessac
- Schüchtermann-Klinik - Bad Rothenfelde
- Herzzentrum Dresden GmbH Universitätsklinik - Dresden
- Universitätsklinikum Düsseldorf - Düsseldorf
- Albertinen-Herz- und Gefäßzentrum - Hamburg
- Herzzentrum Leipzig - Leipzig
- Deutsches Herzzentrum München Klinik an der TU München - München
New York
- Mount Sinai Medical Center - New York
- Saint Francis Hospital - Roslyn
- Saint Josephs Hospital Health Center - Syracuse
Texas
- Baylor St. Luke's Medical Center - Houston
- The Heart Hospital Plano - Plano
Georgia
- WellStar Kennestone Hospital - Marietta
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Duke University Medical Center - Durham
Ohio
- University Hospitals Cleveland - Cleveland
Pennsylvania
- University of Pittsburgh Medical Center UPMC Presbyterian - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2039-12-31 |
What NCT04073420 shows while recruiting
NCT04073420 is an observational study that tracks outcomes without assigning an intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, above the 191-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (1314% higher).
The record links to 1 condition, with Valve Disease, Heart appearing as the primary indexed condition, and to 2 interventions - of which Surgical Heart Valve Repair Products is the first listed.
NCT04073420 names 20 study sites across 9 states, led by Other, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT04073420 about?
NCT04073420 is a clinical study titled "Medtronic Cardiac Surgery PMCF Registry". This registry is being conducted to support ongoing post-market surveillance activities.
What is the current status of trial NCT04073420?
This trial is currently recruiting. The enrollment target is 2,700 participants. The study started on 2019-12-02. Estimated completion is 2039-12-31.
What conditions does trial NCT04073420 study?
This clinical trial studies the following conditions: Valve Disease, Heart.
What interventions are being tested in trial NCT04073420?
The interventions under investigation include: Surgical Heart Valve Repair Products (DEVICE), Surgical Heart Valve Replacement Products (DEVICE).
Who is sponsoring clinical trial NCT04073420?
This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04073420 being conducted?
This trial has 20 study locations across Georgia, Michigan, New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Valve Disease, Heart
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
RECRUITING
-
Allogeneic Valve Transplantation
RECRUITING · NA
-
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
RECRUITING
-
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
- NCT07029490 · 2,700 participants · NA
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI